// App-Quantinova.ai

2146 : Multidimensional Vascular Evaluation in Patients Treated with Tyrosine Kinase Inhibitors (TKIs): From Plaque Formation to Evolution and Follow up on 150 Patients

Researchers

Presenter

  • Elisabetta Abruzzese

Principal Investigators

  • Rossana Gloria

  • Andrea Siani

  • Carla Mazzone

  • Matteo Molica

  • Teresa Dentamaro

  • Luca Cupelli

  • Malgorzata Monika Trawinska

  • Paolo De Fabritiis

Medical Centers

  • Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy

  • Angiology, S. Eugenio Hospital, ASL Roma2, Rome, Italy

  • Vascular Surgery, S. Eugenio Hospital, ASL Roma2, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Peripheral artery disease

  • Chronic Myelogenous Leukemia

  • Acute lymphoblastic leukemia

  • Coronary Artery Disease

  • Hypertension

  • Venous thrombosis

  • Diabetes

  • Obesity

Biomarkers

  • Breakpoint Cluster Region

  • Apoptotic body index

Drug/Treatment

  • Bosutinib

  • Nilotinib

  • Ponatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved